KLK3 and posterior cortical atrophy: Clinical data included the NCCN risk group [47], prostate-specific antigen (PSA) value, International Society of Urological Pathology (ISUP) grade group [48], which ranges from low grade (1) to high grade (5), and the type of PCa treatment received within 12 months of diagnosis.